Kintara Therapeutics Inc Stock price
Is Kintara Therapeutics Inc a Top Scorer Stock based on the Dividend, High-Growth-Investing or Leverman Strategy?
As a Free StocksGuide user, you can view scores for all 9,133 stocks worldwide.
Key metrics
Kintara Therapeutics Inc Stock Analysis
Analyst Opinions
10 Analysts have issued a Kintara Therapeutics Inc forecast:
Analyst Opinions
10 Analysts have issued a Kintara Therapeutics Inc forecast:
Kintara Therapeutics Inc Events
Past Events
|
AUG
18
Shareholder/Analyst Call - TuHURA Biosciences, Inc.
about one month ago
|
Don't miss a Thing! We will send you all news about Kintara Therapeutics Inc directly to your mailbox free of charge.
If you wish, we will send you an e-mail every morning with news on stocks of your portfolios.
Kintara Therapeutics Inc Stock News
Company Profile
Kintara Therapeutics, Inc. is a clinical and biopharmaceutical company, which focuses on the development and commercialization of new cancer therapies. Its pipeline includes the VAL-083 and REM-001. The company was founded by Jeffrey A. Bacha, Dennis M. Brown, and William J. Garner on June 24, 2009 and is headquartered in San Diego, CA.
| Head office | United States |
| CEO | Dr. Bianco |
| Employees | 22 |
| Founded | 2009 |
| Website | tuhurabio.com |


